About H1N1 vaccine, H1N1vaccine production, H1N1 vaccine manufacturers

WHAT:
In a review article appearing in the New England Journal of Medicine, scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, examine research under way to address the limitations of currently available influenza vaccines and develop more efficient and reliable strategies to make vaccines to protect against seasonal as well as pandemic influenza. Although licensed seasonal flu vaccines safely and effectively protect most people who receive them from illness and death, the degree of protection varies depending on how well the circulating virus strains and those in the vaccine match. A vaccine recipient’s age and health status also can affect the effectiveness of influenza vaccination.

The authors discuss the spectrum of ongoing influenza vaccine research that may transform the field in decades to come. Efforts to grow the vaccine virus in cells rather than eggs are currently under way and there is consideration of the addition to influenza vaccine of immune-stimulating adjuvants to be used in certain groups of individuals. Other approaches under development include influenza vaccines based on recombinant virus proteins, non-infectious virus-like particles, harmless vectors or influenza DNA.  Also under intense study is the ultimate goal, a so-called universal flu vaccine that would provide protection against multiple strains of influenza, reducing the need for yearly flu shots while simultaneously protecting against novel flu viruses that may arise in the future.

To further protect vulnerable populations such as the elderly and those with underlying chronic diseases from seasonal influenza, as well as to quickly control the spread of potential pandemic influenza viruses, influenza vaccine makers of the future must use novel production technologies, the authors note.

More information about vaccine technologies and influenza vaccines is available on the NIAID Flu Web portal and at the Advances in Influenza Vaccine Technologies videocast.

ARTICLE:
AS Fauci and L Lambert. Influenza vaccines for the future. New England Journal of Medicine DOI: 10.1056/ NEJMra1002842 (2010).

WHO:
NIAID Director Anthony S. Fauci, M.D., is available to comment on the article.

CONTACT:
To schedule interviews, please contact Nalini Padmanabhan, 301-402-1663, niaidnews

View the Original article

Related posts:

1. H1N1 vaccine production – H1N1 “Swine Flu” Vaccine Market Review (Revenues, Forecasts, Lessons for Future Pandemic Vaccines)
2. Will getting the H1N1 vaccine prevent me from having more immunity in the future?
3. Flu shot is urged for all – Experts say it’s OK to get vaccines early
4. H1N1 vaccine production – Swine Flu Vaccine Close To Reality According to Experts
5. Guidance for the Prevention and Control of Influenza in the Peri- and Postpartum Settings